These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 15537486

  • 21. Patients with peripheral arterial disease in the CHARISMA trial.
    Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA, CHARISMA Investigators.
    Eur Heart J; 2009 Jan; 30(2):192-201. PubMed ID: 19136484
    [Abstract] [Full Text] [Related]

  • 22. [The future prospects of antithrombotic therapy in peripheral vasculopathy].
    Violi F, Loffredo L, Annessi M.
    Ann Ital Med Int; 1999 Jan; 14(3):185-91. PubMed ID: 10566184
    [Abstract] [Full Text] [Related]

  • 23. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H, Hiatt WR.
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [Abstract] [Full Text] [Related]

  • 24. Variability in responsiveness to clopidogrel in patients with intermittent claudication.
    Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J.
    Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):71-5. PubMed ID: 16549375
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders.
    Lacroix P, Aboyans V, Voronin D, Le Guyader A, Cautrès M, Laskar M.
    Int J Clin Pract; 2008 Jan; 62(1):59-64. PubMed ID: 18028389
    [Abstract] [Full Text] [Related]

  • 27. Emerging drugs in peripheral arterial disease.
    Tulsyan N, Ouriel K, Kashyap VS.
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
    [Abstract] [Full Text] [Related]

  • 28. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM.
    J Am Board Fam Pract; 2001 Mar; 14(6):443-50. PubMed ID: 11757887
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN, Modrall JG.
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antiplatelet therapy: a vascular medicine perspective.
    Olin JW.
    Manag Care; 2000 May 12; 9(5 Suppl):11-4. PubMed ID: 11729407
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.